BIOLASE, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Concentrations (Tables)

Concentrations (Tables)

12 Months Ended

Dec. 31, 2017

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the years ended December 31, 2017, 2016 and 2015 are as follows:

				Years Ended December 31,
	2017								2016								2015
Laser systems		29,121			62.0		%			35,150			67.9		%			32,691			67.5		%
Imaging systems		3,685			7.9		%			3,066			5.9		%			2,237			4.6		%
Consumables and other		7,332			15.6		%			6,906			13.3		%			6,877			14.2		%
Services		6,660			14.2		%			6,539			12.6		%			6,465			13.3		%
License fees and royalties		128			0.3		%			149			0.3		%			205			0.4		%
Total revenue		46,926			100.0		%			51,810			100.0		%			48,475			100.0		%